LAURUS LABS LTD.

NSE : LAURUSLABSBSE : 540222ISIN CODE : INE947Q01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE391.75-0.45 (-0.11 %)
PREV CLOSE ( ) 392.20
OPEN PRICE ( ) 392.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 98957
TODAY'S LOW / HIGH ( )389.45 395.95
52 WK LOW / HIGH ( )279.65 444.5
NSE392.350.15 (+0.04 %)
PREV CLOSE( ) 392.20
OPEN PRICE ( ) 391.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 392.35 (828)
VOLUME 1534903
TODAY'S LOW / HIGH( ) 389.55 396.25
52 WK LOW / HIGH ( )278.85 444.7
Exchange
Period From    
Period To    
Exchange Deal Date Client Name Tran Qty (000's) Trade Price () Value (Rs.in Lakhs) Close Price ()

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.